Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

New virus threatens a million

Annabel Ferriman
Saturday 06 April 1996 23:02 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

SCIENTISTS have discovered a new hepatitis virus, which they think is carried by more than a million people in Britain and which can be transmitted through blood transfusions and blood products.

Doctors fear that the virus, provisionally called Hepatitis G or GBV- C, could cause serious liver disease including cirrhosis and cancer, and could be even more widespread than Hepatitis B, which affects 350 million people worldwide.

They want more resources to be channelled into developing an effective screening test.

The discovery of the new virus comes less than a decade after the Hepatitis C virus was isolated, and only five years since a test for that virus was introduced into the blood transfusion service. It is now thought that about 300,000 people in the UK are infected with Hepatitis C, of whom 70,000 could develop cirrhosis or cancer of the liver. More than 5,000 contracted the disease through blood transfusions.

"The isolation of this new virus is a very important scientific discovery," said Dr Geoffrey Dusheiko, reader in medicine at the Royal Free Hospital School of Medicine in London. "There is an urgent need to develop a simple antibody test.

"About 1.5 per cent of blood donors have been found to be positive for the virus, using what is known as a polymerase chain reaction (PCR) test. This test is not suitable for screening large numbers of donors.

"We need to study Hepatitis G positive blood donors, to discover whether they have underlying silent liver disease. All this needs to be begun as soon as possible."

Dr Lesley Kay, consultant haematologist and medical director of Medical Diagnostic Laboratories Ltd, said that this latest discovery was "the story of the blood transfusion service over the last 15 years. We are always chasing the next virus.

"New viruses will continue to appear while we have exotic holidays, foreign travel and sexual freedom. These viruses often exist in small human or animal populations for many years without spreading. Visitors travel to the region, contract the virus and take it back home. It enters the blood supply and is spread by that route or by sexual transmission."

Two groups of scientists in the United States appear to have independently identified the new virus.

Professor Arie Zuckerman, of the World Health Organisation Collaborating Centre for Reference and Research on Viral Diseases at the Royal Free Hospital, said: "We don't have a lot of data about it. It has been found in some patients with acute or chronic hepatitis, fulminant hepatitis in Japan, intravenous drugs users, haemophiliacs, frequently transfused patients and blood donors.

"Much more work needs to be done on the virus, but there is inadequate support for hepatitis research in Britain."

The Department of Health admitted yesterday that a test was needed but said it was not carrying out any work to find one. A spokesman said: "The Committee on the Microbiological Safety of Blood and Tissue for Transplant was appraised of the available information on Hepatitis G in January.

"We are at an early stage of clinical knowledge," he added.

A Medical Research Council spokesman said: "Applications for research work on hepatitis are treated like any other application. But there is not enough money to go round."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in